Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation(CLL-X4 Trial)
Phase of Trial: Phase II
Latest Information Update: 26 Sep 2016
At a glance
- Drugs Ofatumumab (Primary) ; Dexamethasone
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 16 Sep 2016 Status changed from recruiting to completed.
- 20 Mar 2013 New source identified and integrated: European Clinical Trials Database record.
- 19 Mar 2013 New trial record